Archives

by in
Entry Author Date Location
Inviragen, Global Health Vaccine Maker, Bought by Takeda for $35M 05/08/13 Boulder/Denver
East Coast Life Sciences Roundup: GSK, Protein Sciences, IMS Health 03/15/13 Boston
Protein Sciences’ Pitch: a “Pure” Flu Vaccine Alternative 03/11/13 New York
Zuckerberg Takes a Small Step in Right Direction, Backing Biotech 02/25/13 National
Harvard i-lab Sprouts Startups: Nucleik, PollVaultr, Vaxess, & More 01/28/13 Boston
Leprosy 2013 – The Problem and the Solutions 01/25/13 Seattle
Oncothyreon Cancer Drug Fails in Final Trial; Shares Tank 12/19/12 Seattle
East Coast Life Sciences Roundup: Selecta, Rib-X, Cambridge, & More 11/30/12 Boston
Seattle Biomed, Emerald Bio and Peers Get Big NIH Contract Extension 11/19/12 Seattle
San Diego Life Sciences Roundup: Optimer, Pfenex, OncoSec, & More 10/19/12 San Diego
Genocea Snags $30M from Gates Foundation, VCs for New Vaccines 10/10/12 Boston
Vaxxas Entices Merck to Try Needle-Free Vaccine Technique 10/08/12 Boston
We Have To Do Better on TB, In King County and High-Burden Countries 09/24/12 Seattle
IDRI, Medicago To Test Self-Injectable Pandemic Flu Vaccine 08/16/12 Seattle
Life Science Innovation NW Notes: SeaGen, NanoString, Viket, & More 07/12/12 Seattle
Gates Foundation’s Jeff Raikes To Start Off Seattle Biotech Event 07/10/12 Seattle
Life Sciences Discovery Fund Gets New Leader, A Familiar Face 07/03/12 Seattle
Building Bridges in a New Global Health Landscape 06/04/12 Seattle
IDRI, Aeras Team Up to Develop Tuberculosis Vaccine 05/09/12 Seattle
Dendreon CEO John Johnson: ‘This is My Last Stop’ 04/17/12 Seattle
Mymetics Ropes in Dendreon, KPCB Vets to Restart Vaccine Developer 04/11/12 San Francisco
Oncothyreon Marches On With ‘Son of Stimuvax’ Cancer Vaccine 04/10/12 Seattle
In Boston Life Sciences News: Akili, Kala, And Genocea 03/16/12 Boston
Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum 03/15/12 Boston
Harvard-Born TremRx Pursues New Vaccine Technology 02/29/12 Boston
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
NanoBio, Merck to Collaborate on Gates-Funded RSV Vaccine 12/09/11 Detroit
PATH CEO Chris Elias Resigns For Top Anti-Poverty Job at Gates Foundation 10/31/11 Seattle
Sloan-Kettering Spinoff Adjuvance Gains Traction For Vaccine Tech 10/27/11 New York
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs 10/27/11 Boston
Page 1 of 8 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.